Analytical assessment of interleukin-23 and-27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a) AA Hafez, AA Vasmehjani, R Baharlou, SDM Nasab, MH Davami, A Najafi, ... Hepatitis monthly 14 (9), 2014 | 22 | 2014 |
Serological Study on Cytomegalovirus and Toxoplasma Gondii in Thalassemia Major Patients of Yazd, Iran M Moghimi, M Doosti, A Najafi, M Shayestehpour Iranian Journal of Pediatric Hematology Oncology 5 (3), 2014 | 22 | 2014 |
Effects of fennel, asafetida and ginseng ethanolic extracts on growth and proliferation of mouse breast cancer 4T1 cell lines AH Mansourabadi, A Shams, R Mansouri, A Najafi, M Ajami Advanced Herbal Medicine 1 (2), 34-39, 2015 | 11 | 2015 |
Green tea-mediated synthesis of silver nanoparticles: Enhanced anti-cancer activity and reduced cytotoxicity melanoma and normal murine cell lines M Golpour, P Ebrahimnejad, ZR Gatabi, A Najafi, A Davoodi, R Khajavi, ... Inorganic Chemistry Communications 161, 111989, 2024 | 2 | 2024 |
Evaluation of mRNA Expressions of TOX and NR4As in CD8+ T cells in Acute Leukemia M Mohammadi, H Asgarian-Omran, B Najafi, A Najafi, R Valadan, ... Iranian Journal of Immunology 20 (4), 438-445, 2023 | 1 | 2023 |
Expression of galectin-9-related immune checkpoint receptors in B-cell acute lymphoblastic leukemia A Akbar, H Asgarian-Omran, R Valadan, MM Dindarloo, A Najafi, ... Iranian Journal of Basic Medical Sciences 26 (12), 1468, 2023 | 1 | 2023 |
Effective delivery of anti-PD-L1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines M Rajabinejad, R Valadan, M Tehrani, A Najafi, R Negarandeh, M Saeedi, ... Medical Oncology 41 (6), 1-7, 2024 | | 2024 |
Single domain antibodies specific for HER2 dimerization domain effectively disrupts HER2 dimerization A Najafi, R Valadan, H Asgarian-Omran, A Rafiei, M Tehrani International Immunopharmacology 124, 110999, 2023 | | 2023 |
A seromolecular study to determine the prevalence of cytomegalovirus in pregnant women referred to health centers in the north of Iran NM Saravi, F Aghajani, A Najafi, R Khajavi, Z Rahmani, H Jalali, ... Iranian Journal of Microbiology 15 (4), 594, 2023 | | 2023 |
Evaluation of mRNA Expression of CD244 and Its Adapter Molecules in CD8+ T Cells in Acute Leukemia M Mohammadi, H Asgarian-Omran, A Najafi, R Valadan, H Karami, ... Iranian biomedical journal 27 (4), 214, 2023 | | 2023 |
The Association between Laboratory Biomarkers and Clinical Features in COVID-19 Pneumonia: as a Potential Tools for Prognostic and Severity of Disease H Jalali, A Najafi, L Davoodi, A Alipour, MR Mahdavi Research in Molecular Medicine 11 (1), 0-0, 2023 | | 2023 |
Immune response evaluation after Sputnik V vaccination in Sari healthcare population A Najafi, H Jalali, Y Noshi, M Mahdavi, MRM Amiri The Journal of Medical Investigation 70 (3.4), 317-320, 2023 | | 2023 |
Relative Expression of BATF and CD112 in PBMC of Patients with Chronic Lymphocytic Leukemia A Najafi, M Sabaghi, H Asgarian-Omran, R Valadan, R Shekarriz, ... Asian Pacific Journal of Cancer Prevention: APJCP 24 (6), 2171, 2023 | | 2023 |
Genetic Polymorphisms of Cytotoxic T‐Lymphocyte Antigen 4 (CTLA‐4) and clinical outcomes post‐allogeneic hematopoietic stem cell transplantation: A systematic review and meta … A Najafi, R Alizadeh‐Navaei, S Rahimi, R Valadan, M Tehrani Clinical Transplantation 35 (8), e14364, 2021 | | 2021 |
Comparison between interleukine-17 levels by NK-T cells in patients with chronic hepatitis C and healthy individuals A Najafi, A Shams, A Ahmadi-Vasmehjani, SA Mirghanizadeh-bafghi, ... Iranian Journal of Virology 8 (4), 2014 | | 2014 |